301060.SZ SHZ
Shanghai Labway Clinical Laboratory Co., Ltd.
1W: +0.7%
1M: +12.3%
3M: +37.1%
YTD: +5.0%
1Y: +12.2%
3Y: -26.9%
¥12.02 ($1.79)
+0.24 (+2.04%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$216M
-60.5% ▼
5Y CAGR: +25.1%
Capital Expenditures
$77M
+80.8% ▲
5Y CAGR: +14.2%
Free Cash Flow
$140M
-5.7% ▼
5Y CAGR: +35.1%
Dividends Paid
$7M
+94.6% ▲
Buybacks
$13M
-24.3% ▼
Net Change in Cash
-$33M
-116.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $134M | $262M | $739M | -$162M | -$99M |
| Depreciation & Amort. | $44M | $59M | $78M | $65M | $78M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$29M | -$124M | -$983M | $452M | $82M |
| Other Non-Cash Items | $19M | $26M | $250M | $210M | $155M |
| Operating Cash Flow | $168M | $224M | $84M | $547M | $216M |
| — Investing Activities — | |||||
| Capital Expenditures | -$45M | -$119M | -$230M | -$399M | -$77M |
| Acquisitions (Net) | $53M | $13M | $2K | -$11M | $4M |
| Investment Purchases | -$439M | -$941M | -$305M | -$240M | -$232M |
| Investment Sales | $560M | $651M | $711M | $247M | $231M |
| Other Investing | -$45M | -$8M | $5M | $5M | $6M |
| Investing Cash Flow | $84M | -$403M | $180M | -$398M | -$69M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $2M | $180M | $200M | -$99M |
| Stock Repurchased | $0 | $0 | $0 | -$10M | -$13M |
| Dividends Paid | -$35M | -$302K | -$126M | -$137M | -$7M |
| Other Financing | -$61M | $118M | -$4M | -$8M | -$61M |
| Financing Cash Flow | -$96M | $120M | $50M | $45M | -$180M |
| Net Change in Cash | $155M | -$60M | $314M | $193M | -$33M |
| Cash End of Period | $412M | $351M | $666M | $858M | $826M |
| Free Cash Flow | $123M | $105M | -$146M | $148M | $140M |